Fig. 2 Course of BMD at the lumbar
spine during the three years of therapy (+ SD).
Table 4. Occurrence of new vertebral
fractures during study
Group A
(MFP/Ca (interm.)
Group B
(MFP/Ca (cont.)
Group C
(Ca only)
After 1 year
4/4(10.5)
10/6
9/9(21.9)
After 2 years
4/4(11.4)
6/6(18.7
16/14(35.9)
After 3 years
1/1(3.1)
1/1(3.3)
11/11(32.4)
Within 3 years
9/8
17/12
36/30
Patient 3 years
105
100
114
New fractures per 100 patient years
8.6
17.0
31.6
Values are number of fractures/number of
patients (%)
These statement on
mericon-industries.com have not been evaluated by the Food and Drug
Administration. The
products and research on this website are not intended to diagnose, treat or cure or prevent disease.